Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

Presentation TCT 2014

The Five Multislice CT Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Jonathon A. Leipsic

September 14, 2014

Presentation TCT 2014

The Five Echocardiographic Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn

September 14, 2014

Presentation TCT 2014

Multi-device Patient-Specific TAVR Now or in the Future?

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Raj Makkar

September 14, 2014

Presentation TCT 2014

Lessons From the CHOICE Trial

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Mohamed Abdel-Wahab

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, John G. Webb

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Nicolo Piazza

September 14, 2014

Presentation TCT 2014

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Michael J. Reardon

September 14, 2014

Advertisement

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Updates to CoreValve Extreme Risk Study Encouraging

The Five Multislice CT Essentials for Optimal TAVR

The Five Echocardiographic Essentials for Optimal TAVR

Multi-device Patient-Specific TAVR Now or in the Future?

Lessons From the CHOICE Trial

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content